Tamara Shenkier
Overview
Explore the profile of Tamara Shenkier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
2894
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Widman A, Shah M, Frydendahl A, Halmos D, Khamnei C, Ogaard N, et al.
Nat Med
. 2024 Jun;
30(6):1655-1666.
PMID: 38877116
In solid tumor oncology, circulating tumor DNA (ctDNA) is poised to transform care through accurate assessment of minimal residual disease (MRD) and therapeutic response monitoring. To overcome the sparsity of...
2.
Ko J, Roze des Ordons A, Ballard M, Shenkier T, Simon J, Fyles G, et al.
BMJ Open
. 2024 Jan;
14(1):e078385.
PMID: 38286701
Objectives: The Serious Illness Conversation Guide (SICG) has emerged as a framework for conversations with patients with a serious illness diagnosis. This study reports on narratives generated from open-ended questions...
3.
Zaikova E, Cheng B, Cerda V, Kong E, Lai D, Lum A, et al.
NPJ Breast Cancer
. 2024 Jan;
10(1):3.
PMID: 38182588
Circulating tumour DNA (ctDNA) detection via liquid biopsy is an emerging alternative to tissue biopsy, but its potential in treatment response monitoring and prognosis in triple negative breast cancer (TNBC)...
4.
LeVasseur N, Sun J, Fenton D, Baxter S, Chan A, Roberts S, et al.
Clin Breast Cancer
. 2021 Oct;
22(1):e74-e79.
PMID: 34690081
Purpose: The use of the 21-gene Recurrence Score (RS) assay is emerging in node-positive estrogen receptor (ER)+ HER2-negative breast cancer (BC), particularly as initial data from the RxPONDER trial are...
5.
Ko J, Ballard M, Shenkier T, Simon J, Roze des Ordons A, Fyles G, et al.
Palliat Med Rep
. 2021 Jul;
1(1):280-290.
PMID: 34223487
The serious illness conversation (SIC) is an evidence-based framework for conversations with patients about a serious illness diagnosis. The objective of our study was to develop and validate a novel...
6.
Sawatzky B, Edwards C, Walters-Shumka A, Standfield S, Shenkier T, Harris S
Spinal Cord
. 2021 Apr;
59(6):700-704.
PMID: 33828245
Aging women face increased risks of both breast cancer and spinal cord injury (SCI). Unique treatment challenges for this population warrant consideration. Despite advances in breast cancer treatments, significant adverse...
7.
Bland K, Kirkham A, Bovard J, Shenkier T, Zucker D, McKenzie D, et al.
Clin Breast Cancer
. 2019 Oct;
19(6):411-422.
PMID: 31601479
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse effect of taxanes. We sought to evaluate the effect of exercise on taxane CIPN in women with breast cancer. Patients And...
8.
Kirkham A, Bland K, Zucker D, Bovard J, Shenkier T, McKenzie D, et al.
Med Sci Sports Exerc
. 2019 Sep;
52(2):278-286.
PMID: 31490858
Purpose: The purpose of this study was to provide a rationale for "chemotherapy-periodized" exercise by characterizing cyclical variations in fatigue and exercise response across a chemotherapy cycle and comparing exercise...
9.
Zhao E, Shen Y, Pleasance E, Kasaian K, Leelakumari S, Jones M, et al.
Clin Cancer Res
. 2017 Dec;
23(24):7521-7530.
PMID: 29246904
Recent studies have identified mutation signatures of homologous recombination deficiency (HRD) in over 20% of breast cancers, as well as pancreatic, ovarian, and gastric cancers. There is an urgent need...
10.
Dosani M, Schrader K, Nichol A, Sun S, Shenkier T, Lohn Z, et al.
Cureus
. 2017 Sep;
9(7):e1458.
PMID: 28929041
Ataxia telangiectasia mutated (ATM) gene mutations may confer increased sensitivity to ionizing radiation and increased risk of late toxicity for cancer patients. We present the case of a 55-year-old female...